Unity Biotechnology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,902 |
Gross Profit | 664 | -216 | -221 | -227 |
EBITDA | -14,285 | -6,265 | -5,058 | -5,563 |
EBIT | -13,621 | -6,481 | -5,279 | -5,790 |
Net Income | -8,440 | -6,481 | -5,279 | -5,790 |
Net Change In Cash | 0 | 0 | 0 | 1,902 |
Free Cash Flow | -5,905 | -5,193 | -4,584 | -5,183 |
Cash | 7,580 | 8,898 | 7,584 | 7,430 |
Basic Shares | 16,827 | 16,849 | 16,815 | 16,785 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $236 | $4,784 |
Gross Profit | -19,699 | -1,944 | 1,904 | |
EBITDA | -31,171 | -37,283 | -38,731 | -54,668 |
EBIT | -38,465 | -40,911 | -57,548 | |
Net Income | -25,990 | -39,860 | -57,747 | -60,039 |
Net Change In Cash | 0 | 0 | 236 | 4,784 |
Cost of Revenue | -20,719 | |||
Free Cash Flow | -20,865 | -37,099 | -51,125 | -45,255 |
Cash | 7,580 | 19,803 | 12,736 | 32,905 |
Basic Shares | 16,827 | 14,773 | 9,494 | 5,581 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.50 |
2024-09-30 | -$0.38 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.34 |
